nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2026, 13, v.67 1373-1377
周绍华“病、症、证结合”分期论治帕金森病经验
基金项目(Foundation): 中国中医科学院西苑医院名老中医经验传承研究专项(XYZX0101-10); 山西省基础研究计划(202203021211013); 国家中医药管理局高水平中医药重点学科建设项目(ZYYZDXK-2023224)
邮箱(Email): guospringrry@163.com;
DOI: 10.13288/j.11-2166/r.2026.13.004
发布时间: 2026-07-02
出版时间: 2026-07-02
移动端阅读
摘要:

总结周绍华教授“病、症、证结合”分期论治帕金森病的临证经验。认为肾精亏虚为发病之本,痰瘀蕴毒为恶化之关键。将帕金森病分为前驱期、早期及中晚期。前驱期治疗以补肾填髓为本,选用左归丸或右归丸,并针对便秘、快速眼动睡眠行为障碍等非运动症状随症加减;早期辨证分为肝肾阴虚风动、脾肾阳虚、痰浊壅盛三型,主张“治风先治血”,分别以大定风珠、右归丸、金水六君煎为基础方,合用四物汤养血熄风;中晚期补肾固元与解毒化浊并举,加鹿角胶、龟甲等血肉有情之品,联合黄连解毒汤清热解毒化浊、攻补兼施,重视体位性低血压、吞咽困难等非运动症状的中西医协同调治。

Abstract:

This paper aims to summarize Professor ZHOU Shaohua's clinical experience in treating Parkinson's disease(PD) based on the "disease-symptom-syndrome integration" approach. It is believed that kidney essence deficiency is the root cause of the disease, and phlegm-stasis accumulating toxin is the key factor for its deterioration. PD could be divided into the prodromal stage, early stage and middle-late stage. In the prodromal stage, treatment focuses on tonifying the kidney and replenishing marrow, choosing Zuogui Pill (左归丸) or Yougui Pill (右归丸) to prescribe with modifications according to accompanying non-motor symptoms such as constipation and rapid eye movement sleep behavior disorder. For the early stage, the disease is differentiated into three syndromes, liver-kidney yin deficiency with stirring wind, spleen-kidney yang deficiency, and excessive phlegm turbidity, then following the principle of "calming wind by regulating blood first", the basic prescriptions of Dading Fengzhu Pill (大定风珠), Yougui Pill (右归丸) and Jinshui Liujun Decoction (金水六君煎) are applied respectively, combined with Siwu Decoction (四物汤) to nourish blood and extinguish wind. For the middle-late stage, therapies of tonifying the kidney and consolidating original qi are combined with detoxifying and resolving turbidity, prescribing fleshy and nourishing medicinals such as deer-horn glue(Cervus nippon Temminck) and turtle shell glue(Colla Carapacis et Plastri Testudinis), together with Huanglian Jiedu Decoction (黄连解毒汤) to clear heat, detoxify and resolve turbidity, implementing simultaneous tonification and elimination. Integrated traditional Chinese and western medicine intervention is emphasized for nonmotor symptoms including orthostatic hypotension and dysphagia.

参考文献

[1]Bloem B R, Okun M S, Klein C. Parkinson's disease[J].The Lancet, 2021, 397(10291):2284-2303.

[2]Berg D, Postuma R B, Adler C H, et al. MDS research criteria for prodromal Parkinson's disease[J]. Movement Disord, 2015, 30(12):1600-1611.

[3]Schapira A H V, Chaudhuri K R, Jenner P. Non-motor features of Parkinson disease[J]. Nat Rev Neurosci,2017, 18(7):435-450.

[4]Postuma R B, Iranzo A, Hu M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder:a multicentre study[J]. Brain, 2019,142(3):744-759.

[5]中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍学组.中国帕金森病治疗指南(第四版)[J].中华神经科杂志,2020,53(12):973-986.

[6]Connolly B S, Lang A E. Pharmacological treatment of Parkinson disease:a review[J]. JAMA, 2014, 311(16):1670-1683.

[7]帕金森病自主神经功能障碍中西医结合诊治专家共识写作组.帕金森病自主神经功能障碍中西医结合诊治专家共识(2020)[J].南京中医药大学学报,2021,37(1):6-12.

[8]帕金森病运动并发症中西医结合诊治专家共识写作组.帕金森病运动并发症中西医结合诊治专家共识(2020)[J].中国神经免疫学和神经病学杂志,2020,27(4):247-252.

[9]雒晓东,李哲,朱美玲,等.帕金森病(颤拘病)中医临床诊疗专家共识[J].中医杂志,2021, 62(23):2109-2116.

[10]中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍病专业委员会.帕金森病前驱期诊断研究标准中国专家共识[J].中华老年医学杂志,2019,38(8):825-831.

[11]Heinzel S, Berg D, Gasser T, et al. Update of the MDS research criteria for prodromal Parkinson's disease[J].Movement Disord, 2019, 34(10):1464-1470.

[12]Nonnekes J, Snijders A H, Nutt J G, et al. Freezing of gait:a practical approach to management[J]. Lancet Neurol, 2015, 14(7):768-778.

[13]Fasano A, Visanji N P, Liu L W C, et al. Gastrointestinal dysfunction in Parkinson's disease[J]. Lancet Neurol, 2015, 14(6):625-639.

[14]Seppi K, Chaudhuri K, Coelho M, et al. Update on treatments for nonmotor symptoms of Parkinson's disease:an evidence-based medicine review[J]. Movement Disord,2019, 34(2):180-198.

[15]Bhidayasiri R, Phuenpathom W, Tan A H, et al. Management of dysphagia and gastroparesis in Parkinson's disease in real-world clinical practice:balancing pharmacological and non-pharmacological approaches[J]. Front Aging Neurosci, 2022, 14:979826. DOI:org/10. 3389/fnagi. 2022. 979826.

[16]丁丽丽,施松善,崔健,等.麻黄化学成分与药理作用研究进展[J].中国中药杂志,2006,31(20):1661-1664.

基本信息:

DOI:10.13288/j.11-2166/r.2026.13.004

中图分类号:R249;R277.7

引用信息:

[1]徐丁林,王嘉仪,葛力维,等.周绍华“病、症、证结合”分期论治帕金森病经验[J].中医杂志,2026,67(13):1373-1377.DOI:10.13288/j.11-2166/r.2026.13.004.

基金信息:

中国中医科学院西苑医院名老中医经验传承研究专项(XYZX0101-10); 山西省基础研究计划(202203021211013); 国家中医药管理局高水平中医药重点学科建设项目(ZYYZDXK-2023224)

发布时间:

2026-07-02

出版时间:

2026-07-02

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文